New Drug's first human test: is it safe?
NCT ID NCT06448247
Summary
This early-stage study tested a new drug called SPY001-001 in healthy volunteers to see if it's safe and how the body processes it. Researchers gave different doses to 96 healthy adults and compared them to people receiving a placebo. The main goal was to check for side effects and measure how long the drug stays in the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spyre Site 1
Montreal, Quebec, H3P 3P1, Canada
-
Spyre Site 2
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.